Shanghai Xinzhi BioMed Co., Ltd.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Shanghai Xinzhi BioMed Co., Ltd.
RECRUITINGPhase 1NCT07195825
A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease
The purpose of the study is to evaluate the safety and tolerability of BBM-P002 for stereotactic injection to treat participants with idiopathic Parkinson's Disease (PD) during...
Sponsor: Shanghai Xinzhi BioMed Co., Ltd.Enrolling: 181 location
PD
RECRUITINGPhase 2 / Phase 3NCT06111638
Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
This is a multi-center, Phase 1/2/3, single-arm, open-label, single-dose treatment clinical study to evaluate the safety, tolerability and efficacy of BBM-H803 injection in severe...
Sponsor: Shanghai Xinzhi BioMed Co., Ltd.Enrolling: 5510 locations
Hemophilia A